- Conditions
- Post Term Pregnancy, Premature Rupture of Membrane, Fetal Growth Retardation, Oligohydramnios, Gestational Diabetes, High Blood Pressure in Pregnancy
- Interventions
- Dilapan-S
- Device
- Lead sponsor
- Medicem Technology s.r.o.
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 1,200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2025
- U.S. locations
- 1
- States / cities
- Galveston, Texas
Source: ClinicalTrials.gov public record
Updated Nov 21, 2024 · Synced May 21, 2026, 8:43 PM EDT